Nandana Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.41 Cr
as on 17-12-2024
- Revenue 197.37%
(FY 2022)
- Profit 187.52%
(FY 2022)
- Ebitda 176.31%
(FY 2022)
- Net Worth 44.64%
(FY 2022)
- Total Assets 39.02%
(FY 2022)
About Nandana Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.41 Cr.
Venkateswarlu Muvva, Krishna Gajjela, Sreenivasan Shanmugam, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290TG2019PTC130403
- Company No.
130403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nandana Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateswarlu Muvva  | Managing Director | 08-Feb-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Gajjela | Director | 08-Feb-2019 | Current |
| Sreenivasan Shanmugam | Director | 30-Nov-2019 | Current |
| Muralikrishnan Pagadala | Additional Director | 04-Nov-2020 | Current |
| Yoga | Additional Director | 22-Oct-2021 | Current |
Financial Performance of Nandana Laboratories.
Nandana Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 197.37% increase. The company also saw a substantial improvement in profitability, with a 187.52% increase in profit. The company's net worth Soared by an impressive increase of 44.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nandana Laboratories?
In 2022, Nandana Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 29 Aug 2024 | ₹3.20 Cr | Open |
Axis Bank Limited Creation Date: 07 Nov 2022 | ₹2.10 M | Open |
How Many Employees Work at Nandana Laboratories?
Nandana Laboratories has a workforce of 5 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nandana Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nandana Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
